This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
autonomous-vehicles: Archive
KANZHUN LIMITED Sponsored ADR (BZ) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BZPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
NIO vs. Tesla: Which EV Stock Has the Better Investment Case?
by Rimmi Singhi
Stronger deliveries, sharply higher vehicle margins and a path to positive cash flow make NIO the preferred EV stock over TSLA.
TSLAPositive Net Change NIOPositive Net Change
artificial-intelligence autonomous-vehicles electric-vehicles tech-stocks
Can Serve Robotics' Beacon Overcome Restaurant Integration Barriers?
by Amit Kr Ram
Can Beacon help SERV break restaurant integration barriers and unlock more delivery orders as it expands direct merchant access?
SERVPositive Net Change AIPositive Net Change SYMNegative Net Change
artificial-intelligence autonomous-vehicles computers tech-stocks
Serve Robotics Stock Slides 55% YTD: Should You Buy the Dip or Wait?
by Zacks Equity Research
SERV faces near-term pressure from weaker revenues and Uber uncertainty, but hospital wins, autonomy gains and new use cases offer growth avenues.
SERVPositive Net Change NVDAPositive Net Change AIPositive Net Change SYMNegative Net Change
artificial-intelligence autonomous-vehicles computers tech-stocks
Ouster Is Up 70% YTD: Time to Buy More, Hold or Book Profits?
by Rimmi Singhi
OUST's 70% YTD rally rests on Rev8, Physical AI and StereoLabs growth, but a rich valuation and persistent losses support booking profits.
OUSTNegative Net Change AEVANegative Net Change INVZNegative Net Change HSAIPositive Net Change
artificial-intelligence autonomous-vehicles tech-stocks
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BLTENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Does Slovenia's FSD Approval Bring Tesla Closer to EU-Wide Approval?
by Lavina Shahu
TSLA's FSD approval in Slovenia marks another step toward a potential EU-wide rollout, with an approval vote possible as early as Oct. 6.
TSLAPositive Net Change LCIDPositive Net Change RIVNPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles
Is Tesla's Cybercab Certification Facing a Regulatory Roadblock?
by Zacks Equity Research
TSLA faces a probe into how nearly 1,000 Cybercabs were certified, spotlighting regulatory questions around their driverless design.
TSLAPositive Net Change LCIDPositive Net Change RIVNPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles
Should You Buy Goldman Sachs BDC (GSBD) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GSBDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ASMBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines